Abstract
Clinical, radiological, and histopathological features of 51 surgically treated gangliogliomas were evaluated retrospectively. The most common presenting symptoms were epileptic seizures (47 patients (92%)). Focal neurological deficits occurred in 8% of the patients. The duration of symptoms at the time of operation ranged from three months to 45 years, mean 11 years. The temporal lobe was affected in 43 patients (84%), the frontal lobe in five patients (10%), and the occipital lobe in one patient (2%). Two of the tumours (4%) were localised infratentorially. On MRI, solid tumour parts usually showed a pronounced signal increase on proton density images and a less pronounced signal increase on T2 weighted images, whereas solid components were mainly isointense on Ti weighted images. Contrast enhancement was noted in 16 of cases. All CT and MRI scans were reviewed by a neuroradiologist. Histological preparations of specimens from operation were reviewed by two neuropathologists. In all cases the following stains and immunohistopathological reactions were used: haematoxylin-eosin, Nissl, glial fibrillary acid protein (GFAP), synaptophysin, neurofilament protein (NFP), and neuron specific enolase (NSE). The tumours were classified according to the revised World Health Organisation (WHO) classification for tumours of the nervous system.'6
Results

CLINICAL FINDINGS
There were 29 male and 22 female patients. Ages ranged from 2 to 50 (mean 25) years. Forty seven patients (92%) presented with an epileptic seizure disorder that was pharmacoresistant in 40 cases (78%). The predominant seizure pattern was that of complex partial seizures. In three of the epileptic patients, the psychomotor development was noticeably retarded. Focal neurological deficits were found in four cases (8%). Two patients (4%) presented with signs of increased intracranial pressure (table 1) . At the time of operation the duration of symptoms ranged from three months to 45 (mean 11) years. In patients treated for epilepsy, the mean duration of symptoms was 13 years as opposed to three years in patients operated on without chronic pharmacoresistant seizure disorders.
NEURORADIOLOGICAL FINDINGS
The tumours were located in the temporal lobe in 43 cases (84%), in the frontal lobe in five cases (10%), in the occipital lobe in one case (2%), and infratentorially with involvement of the pons and medulla oblongata in two cases (4%).
Native CT showed a hypodense lesion in 10 of 17 patients (59%). Calcifications were detected in seven cases (41%; fig 1) . Lesion enhancement was present in five of 14 
Discussion
Gangliogliomas are tumours of the CNS that are composed of atypical ganglion cells and astrocytes. Zulch6 found gangliogliomas in 0-4% and Cushing'8 in 0-3% of a comprehensive series of brain tumours. According to recent studies, gangliogliomas account for 0 4 to 7-6% of paediatric CNS neoplasms23' and up to 1-3% of those in adults. 4 The high ratio of gangliogliomas among intrinsic brain tumours at our institution (5-2%) reflects the high incidence of this tumour in patients with epilepsy. [19] [20] [21] The temporal lobe is the most common location of gangliogliomas.356222' Also, gangliogliomas may be found at virtually any location of the CNS such as the spinal cord,24-27 brain stem,28 29 third and fourth ventricle,30 cerebellum,"" pineal region,'23' thalamus,5 and optic nerve.'435
Most patients present with long histories of seizures, whereas focal neurological deficits or increased intracranial pressure are unusual. In our series, epilepsy was found in 47 of 51 patients (92%). This is in agreement with previous reports in which seizures were the presenting symptom in 62 to 100% of patients with hemispheric tumours.' 4 There was no sex preponderance in any of the reported series, including our own.
Our CT findings are similar to other series. The tumours were hypodense in 59%. Calcifications were present in 41 % and there was contrast enhancement in 36%. Hypodense lesions on CT were reported in the literature in 40 to 100%, calcifications in 20 to 50%, and contrast enhancement in 16 to 80% of gangliogliomas.' 4 5 10 11 36 The fact that the tumour was invisible on native CT in two of our patients and on contrast enhanced CT in one case highlights the importance of MRI for the diagnosis of gangliogliomas.
Magnetic resonance imaging has proved to be more sensitive in identifying gangliogliomas than CT. In agreement with previous reports,'01' 57% of the tumours had cystic components, which were hypointense on Tl weighted images and hyperintense on T2 weighted images. Forty three per cent of the tumours appeared only as solid lesions with typically pronounced signal increase on proton density weighted images and less pronounced hyperintensity on T2 weighted images. Most remarkably, there was usually isointensity on Tl weighted images. The pattern of contrast enhancement in MRI studies of gangliogliomas has not been reported in detail in previous studies. The extent of resection is thought to be the main prognostic factor in the treatment of gangliogliomas.' "'I The present results with a complete seizure relief in 80% and a significant improvement (> 75% reduction in seizure frequency) in the remaining 20% of the patients compare favourably with most previous reports on smaller series in which relief of seizures after operation was found in 50-90% of the patients. For most gangliogliomas, radiation therapy seems to be of no benefit.513 None of our patients received postoperative irradiation treatment. Garrido et al' found no difference in outcome with or without radiation therapy in four cases. Most authors recommend that radiation therapy should be reserved only for those patients with tumour progression. 35 3 Whether anaplastic gangliogliomas will benefit from radiation therapy or chemotherapy has not been studied. In one case of anaplastic ganglioglioma in our series, MRI indicated spinal drop metastases 12 months after surgery, which suggests that postoperative radiation therapy might be useful in anaplastic gangliogliomas (WHO grade III). Similarly, the relevance of increased cellularity and cellular and nuclear pleomorphism without frank anaplasia (WHO grade II lesions) remains uncertain at the present time and is awaiting long term follow up.
The origin of gangliogliomas remains obscure. Some findings support the hypothesis that gangliogliomas represent developmental lesions. These include histopathological evidence of disordered neuronal migration and a long clinical history in many patients. A single case of a congenital ganglioglioma of the occipital lobe presenting with quadrantic anopsia has been reported. '8 In conclusion, gangliogliomas are usually benign tumours composed of neuronal and glial elements. The temporal lobes are the preferred site. Clinically, gangliogliomas are typically associated with chronic pharmacoresistant epileptic seizure disorders in children or younger adults. Neuroradiologically, there is no single pathognomonic finding. In the appropriate clinical setting, a ganglioglioma should be strongly considered in the presence of a tumour like lesion with both solid and cystic components on MRI. The presence of calcifications, which are more readily detected by CT than MRI, provides further support for the tentative diagnosis of a ganglioglioma. Complete tumour removal seems to be the treatment of choice. In patients with medically intractable epilepsy, surrounding brain areas that are considered to be epileptogenic as determined by extensive presurgical evaluation should also be excised. Although most gangliogliomas appear histopathologically benign and run a clinically benign course, long term follow up of additional cases is necessary for a clear definition of the biological behaviour of these lesions.
